Searched for
NOVARTIS STAKE SALE
Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...- Citi sees India IPOs hitting fresh records despite challengesIndian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...
- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 croreSwiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This div...
- ChrysCapital, two others launch open offer for Novartis IndiaA consortium including WaveRise Investments, ChrysCapital, and Two Infinity Partners is set to acquire a significant stake in Novartis Indi...
- Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore dealNovartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A c...
- Market volatility derails Novartis' plan to sell stake in its India armNovartis AG's plan to sell its 70.68% stake in Novartis India faces challenges due to market volatility impacting valuation. Despite strate...
- PE firms queue up for Novartis' Indian armThe PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and is also expec...
- Swiss drugmaker Novartis to spin off generics unit SandozThe Basel-based company, which makes a vast array of drugs including cancer treatment Gleevec and Diovan for hypertension, says it wants to...
- Danone, HUL, KKR vie for GSK’s consumer businessAs per Monday’s market value, 72 per cent of GSK is worth around Rs 17,980 crore.
- Novartis India shares jump over 17% on buyback planThe company’s shares closed at Rs 833 on the Bombay Stock Exchange. On May 18, the company had announced it would hold its board meeting on...
- GlaxoSmithKline Consumer Healthcare Ltd India-Novartis deal won't affect business in IndiaGlaxoSmithKline Consumer Healthcare today said the global deal between GlaxoSmithKline Plc and Novartis won't affect its business in India.
- Novartis AG sells 1.42% stake in Indian arm for Rs 25 croreDrug firm Novartis India today said its parent Novartis AG has offloaded 1.42 per cent stake in it through open market for a consideration ...
- Novartis appoints Citigroup as broker for Indian unit share saleDrug major Novartis India said its Swiss promoter Novartis AG has appointed Citigroup Capital Markets as the broker for the proposed share ...
- Aventis completes CBVPL stake sale; pockets Rs 100 crThe company, which completed stake sale on December 23, received sale consideration of Rs 1,007.5mn (USD 22.399mn), Aventis Pharma said in ...
- Aventis to exit JV with Novartis, sell stake for about Rs 100crAventis has agreed to continue to provide certain utilities in services to the Ankleshwar plant of CBVPL for a period of 3 yrs from the dat...
- No shortage of rabies vaccine: Novartis IndiaNovartis India said there was no shortage of rabies vaccine in the country, despite manufacturing constraints at Ankaleswar plant of Chiron...
- Novartis posts 32% rise in Q3 net profitDrug maker Novartis AG on Monday reported a 32-percent rise in net profit for the third quarter due to strong sales and the positive impact...
- Novartis posts 32-pc rise in 3Q net profitDrug maker Novartis AG on Monday reported a 32-per cent rise in net profit for the third quarter, thanks to strong sales and the weakness o...
- Novartis completes first stage in $38 billion takeover of eye-care company AlconNovartis AG said that it has completed the first stage of its US $38 billion takeover of US eye-care company Alcon Inc.
Load More
